Evidence map›Paper›PMID 37398916›Full record

ArticleNMC case report journal2023

A Collision Tumor of Pit-1/SF-1-positive Double Pituitary Adenoma and a Craniopharyngioma Coexisting with Graves' Disease.

Haruhiko Kikuta, Shinya Jinguji, Taku Sato, Mudathir Bakhit, Ryo Hiruta, Yusuke Sato, Rei Sekine, Hayato Tanabe, Masayasu Okada, Kiyoshi Saito and 1 more

Abstract readCase Reports
In one paragraph

Article in NMC case report journal, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Collision tumor of the sellar region: Coexistence of papillary craniopharyngioma and thyrotropin-secreting pituitary adenoma-A case report.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Haruhiko KikutaDepartment of Neurosurgery, Fukushima Medical University, Fukushima, Fukushima, Japan.
Shinya JingujiDepartment of Neurosurgery, Fukushima Medical University, Fukushima, Fukushima, Japan.
Taku SatoDepartment of Neurosurgery, Azuma Neurosurgery Hospital, Fukushima, Fukushima, Japan.
Mudathir BakhitDepartment of Neurosurgery, Fukushima Medical University, Fukushima, Fukushima, Japan.
Ryo HirutaDepartment of Neurosurgery, Fukushima Medical University, Fukushima, Fukushima, Japan.
Yusuke SatoDepartment of Neurosurgery, Okazaki City Hospital, Okazaki, Aichi, Japan.
Rei SekineDepartment of Pathology and Pathophysiology, Fukushima Medical University, Fukushima, Fukushima, Japan.
Hayato TanabeDepartment of Diabetes, Endocrinology and Metabolism, Fukushima Medical University, Fukushima, Fukushima, Japan.
Masayasu OkadaDepartment of Neurosurgery, Niigata University Brain Research Institute, Niigata, Niigata, Japan.
Kiyoshi SaitoDepartment of Neurosurgery, Fukushima Rosai Hospital, Iwaki, Fukushima, Japan.
Masazumi FujiiDepartment of Neurosurgery, Fukushima Medical University, Fukushima, Fukushima, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Double or multiple pituitary adenomas expressing different types of transcription factors and collision tumors of pituitary adenomas and craniopharyngiomas are rare. In this report, we present a case of pituitary adenoma of two different cell populations, Pit-1 and SF-1, and an adenoma and craniopharyngioma collision tumor with coexisting Graves' disease. The patient had a 16-mm pituitary tumor with pituitary stalk calcification and optic chiasm compression but no visual dysfunction. Based on hormonal profile results, the tumor in the sella was considered a nonfunctioning pituitary adenoma; nevertheless, the pituitary stalk was invaded by a different lesion, which was later confirmed to be a craniopharyngioma. Using an endoscopic endonasal approach, the pituitary adenoma was removed; however, a small remnant remained medial to the right cavernous sinus. Because the pituitary stalk lesion was isolated from the pituitary adenoma, it was preserved to maintain pituitary function. Three years after the initial surgery, the patient suffered from Graves' disease and was treated with antithyroid medications. However, the intrasellar residual and pituitary stalk lesions gradually increased in size. A second surgery was performed, and the residual intrasellar and stalk lesions were completely removed. As per the initial and second histopathologies, the pituitary adenoma comprised different cell groups positive for thyroid-(TSH) and follicle-stimulating hormones, and each cell group was positive for Pit-1 and SF-1. The pituitary stalk lesion was an adamantinomatous craniopharyngioma. We believe that TSH-producing adenoma was involved in the development of Graves' disease or that treatment for Graves' disease increased TSH-producing adenoma.

Indexed as

collision tumorcraniopharyngiomadouble pituitary adenomaGraves' diseasepituitary adenoma

Identifiers

PMID37398916
PMCPMC10310352

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.